GlaxoSmithKline

By  MHN Staff 10:28 am April 8, 2016
More and more, pharma companies are making real bets in digital health, and reorganizing their businesses to put some power behind those efforts. The space is, in some ways, quieter than it was this time last year, but there’s reason to believe that quiet is a calm before a storm of activity, driven more by pharma’s tendency to keep early-stage projects close to the chest than by a lack of...
By  Aditi Pai 01:59 pm March 9, 2016
Digital smoking cessation company 2Morrow has partnered with GlaxoSmithKline, makers of Nicoderm patches, to offer the company’s Nicoderm CQ Patch to smokers who complete 2morrow’s cessation program. 2Morrow’s smoking cessation app, called SmartQuit, is based on acceptance and commitment therapy, or an ACT-based program, that "focuses on increasing one’s willingness to accept the physical, mental...
By  Jonah Comstock 12:59 pm January 21, 2016
According to a report in Bloomberg, GlaxoSmithKline is in talks with Qualcomm to create a new joint venture to develop medical technology. Financial Times added in its report that the JV could be worth up to $1 billion. Very little information about the prospective partnership is available, but it makes sense for both companies: Qualcomm has already teamed up with both Roche and Novartis on major...
By  Jonah Comstock 06:14 am December 1, 2015
GSK's Ellipta inhaler GlaxoSmithKline and Madison, Wisconsin-based Propeller Health announced a partnership today in which Propeller will develop and manufacture a custom sensor for GSK's Ellipta inhaler for COPD patients. Like the other inhaler sensors Propeller has developed, the device will record when and where the patient uses the inhaler and wirelessly transmit that information to GSK ...
By  Jonah Comstock 11:20 am November 3, 2015
Over the last two years, big pharma has gotten behind the idea of smartphone-connected inhalers for asthma and COPD in a big way. Two acquisitions, a $3 million investment, and a number of pilot and partnership deals have shown clearly that the space is of interest. (MobiHealthNews is helping to put on two pharma-related events at the mHealth Summit next week -- be sure to join us if you'll be in...
By  Jonah Comstock 12:48 pm October 5, 2015
MedWatcher, from Epidemico. We've written before about Epidemico, a startup that grew out of the Boston Children's Hospital's work on combing social media for medical and health data. Today at the Health 2.0 conference in Santa Clara, California, Greg Powell, director of pharmacovigilance at GlaxoSmithKline, talked about how the pharma company uses the data it collects from its partnership...
By  Jonah Comstock 09:45 am July 22, 2015
Madison, Wisconsin-based Propeller Health has secured two new FDA clearances for new sensors that are designed to work with two particular inhalers on the market: the Diskus inhaler from GlaxoSmithKline and the Respimat inhaler from Boehringer Ingelheim. Unlike previous FDA clearances for Propeller, the new clearances actually allow Propeller to market its new devices as improving — not just...
By  Jonah Comstock 10:22 am July 13, 2015
When Apple first announced ResearchKit, it was met with a fair amount of skepticism about whether the data collected via smartphones would be robust enough to be useful. But just a few scant months after that announcement, it seems many in healthcare are at least paying attention to the possibilities of smartphone-based data collection in general and ResearchKit in particular. Last week the...
By  Jonah Comstock 10:08 am November 17, 2014
Pharmaceutical company GlaxoSmithKline is using mobile health tools in a small study -- just six subjects -- that could lead to there more widespread use in clinical trials. The company is working with data startup Medidata and sensor makers Vital Connect and ActiGraph to evaluate the impact of wearable sensors in clinical trial settings. “Working with GSK on this initiative has provided us with...
By  Jonah Comstock 06:29 am October 27, 2014
Pharmaceutical companies have a lot of apps in the market, and have been making apps for a long time, but their apps aren't seeing downloads and usage on par with the apps from other industries. That's the conclusion of a new report from Research2Guidance (R2G), which analyzed more than 725 apps from 11 pharma companies. According to R2G, the top pharma companies have 65 apps in the Apple and...